Business Standard

Dr Reddy's Lab down 5% to hit 52-week low, top Sensex loser

The stock slipped 5% to Rs 2,602 on BSE in intra-day trade on back of heavy volumes.

reddy, dr reddy's
Premium

Dr Reddy's laboratory

SI Reporter Mumbai
Dr Reddy's Laboratories slipped to its 52-week low of Rs 2,602, down 5% on BSE in intra-day trade on back of heavy volumes.

The BSE said the exchange has sought clarification from Dr Reddys Laboratories on March 21, 2017, with reference to news flashed on ET Now dated March 21, 2017 quoting "US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance."

The reply is awaited.

Earlier, on March 9, 2017, the stock of pharmaceutical company hit a low of Rs 2,702 after it said the US drug regulator issued

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in